BPA|经皮球囊肺动脉成形术在慢性血栓栓塞性肺动脉高压中的应用进展( 五 )


[13] Inami T, Kataoka M, Shimura N, et al. Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty[J]. Cardiovascular Interventions, 2013, 6(7):725-736.
【BPA|经皮球囊肺动脉成形术在慢性血栓栓塞性肺动脉高压中的应用进展】[14] Inami T, Kataoka M, Shimura N, et al. Pressure-Wire-Guided Percutaneous Transluminal Pulmonary Angioplasty[J]. JACC: Cardiovascular Interventions, 2014, 7(11):1297-1306.
[15] Ishiguro H, Kataoka M, Inami T, et al. Diversity of Lesion Morphology in CTEPH Analyzed by OCT, Pressure Wire, and Angiography[J]. Jacc-cardiovascular Imaging, 2016, 9(3): 324-325.
[16] Khan M S, Amin E, Memon M M, et al. Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension[J]. International journal of cardiology, 2019, 291: 134-139.
[17] Kalra R, Duval S, Thenappan T, et al. Comparison of Balloon Pulmonary Angioplasty and Pulmonary Vasodilators for Inoperable Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-Analysis[J]. Scientific Reports, 2020, 10(1): 1-11.
[18] Zoppellaro G, Badawy MR, Squizzato A, et al. Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension - a systematic review and meta-analysis.Circ J. 2019;83:1660–7.
[19] Fukuda K, Date H, Doi S. Guidelines for the treatment of pulmonary hypertension (JCS 2017/JPCPHS 2017)[J]. Circulation Journal, 2019, 83(4): 842-945.
[20] Japanese Circulation Society Joint Working Group. Statement for balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (JCS 2014).
http://www.j-circ. or.jp/guideline/pdf/JCS2014_ito_d.pdf
[21] Lin J L, Chen H M, Lin F C, et al. Application of DynaCT angiographic reconstruction in balloon pulmonary angioplasty[J]. European Radiology, 2020: 1-8.
[22] Velázquez M, Albarrán A, Hernández I, et al. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Observational study in a referral unit[J]. Revista Espa?ola de Cardiología (English Edition), 2019, 72(3): 224-232.
[23] Lewczuk J, Piszko P, Jagas J, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism[J]. Chest, 2001, 119(3): 818-823.
[24] Ogawa A, Satoh T, Fukuda T, et al. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: results of a multicenter registry[J]. Circulation: Cardiovascular Quality and Outcomes, 2017, 10(11): e004029.
[25] Aoki T, Sugimura K, Tatebe S, et al. Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications[J]. European heart journal, 2017, 38(42): 3152-3159.
[26] Kimura M, Kohno T, Kawakami T, et al. Midterm effect of balloon pulmonary angioplasty on hemodynamics and subclinical myocardial damage in chronic thromboembolic pulmonary hypertension[J]. Canadian Journal of Cardiology, 2017, 33(4): 463-470.


推荐阅读